Педиатрическая фармакология (Jan 2014)

CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

  • O. L. Lomakina,
  • E. I. Alexeyeva,
  • R. V. Denisova,
  • T. V. Sleptsova,
  • A. N. Fetisova

DOI
https://doi.org/10.15690/pf.v11i1.905
Journal volume & issue
Vol. 11, no. 1
pp. 93 – 96

Abstract

Read online

The article presents a case of successful use of a preparation of monoclonal antibodies to interleukin 6 receptors (tocilizumab) at asevere systemic juvenile idiopathic arthritis. Tocilizumab treatment promptly provided decrease of clinical and laboratory parametersof the disease activity, increase in the child’s physical activity, systemic juvenile idiopathic arthritis remission development and allowed avoiding per os prescription of glucocorticoids.

Keywords